VEGA–an open platform to develop chemo-bio-informatics applications, using plug-in architecture and script programming A Pedretti, L Villa, G Vistoli Journal of computer-aided molecular design 18, 167-173, 2004 | 879 | 2004 |
Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation G Vistoli, D De Maddis, A Cipak, N Zarkovic, M Carini, G Aldini Free radical research 47 (sup1), 3-27, 2013 | 875 | 2013 |
Rational design and simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, tubastatin A KV Butler, J Kalin, C Brochier, G Vistoli, B Langley, AP Kozikowski Journal of the American Chemical Society 132 (31), 10842-10846, 2010 | 840 | 2010 |
N-Acetylcysteine as an antioxidant and disulphide breaking agent: the reasons why G Aldini, A Altomare, G Baron, G Vistoli, M Carini, L Borsani, F Sergio Free radical research 52 (7), 751-762, 2018 | 689 | 2018 |
VEGA: a versatile program to convert, handle and visualize molecular structure on Windows-based PCs A Pedretti, L Villa, G Vistoli Journal of Molecular Graphics and Modelling 21 (1), 47-49, 2002 | 514 | 2002 |
Type 2 diabetes mellitus: a review of multi-target drugs A Artasensi, A Pedretti, G Vistoli, L Fumagalli Molecules 25 (8), 1987, 2020 | 390 | 2020 |
Assessing drug-likeness–what are we missing? G Vistoli, A Pedretti, B Testa Drug discovery today 13 (7-8), 285-294, 2008 | 315 | 2008 |
Reactions and enzymes in the metabolism of drugs and other xenobiotics B Testa, A Pedretti, G Vistoli Drug discovery today 17 (11-12), 549-560, 2012 | 231 | 2012 |
The carbonyl scavenger carnosine ameliorates dyslipidaemia and renal function in Zucker obese rats G Aldini, M Orioli, G Rossoni, F Savi, P Braidotti, G Vistoli, KJ Yeum, ... Journal of cellular and molecular medicine 15 (6), 1339-1354, 2011 | 223 | 2011 |
Molecular strategies to prevent, inhibit, and degrade advanced glycoxidation and advanced lipoxidation end products G Aldini, G Vistoli, M Stefek, N Chondrogianni, T Grune, J Sereikaite, ... Free radical research 47 (sup1), 93-137, 2013 | 182 | 2013 |
Indole-2-carboxamide-based MmpL3 inhibitors show exceptional antitubercular activity in an animal model of tuberculosis infection J Stec, OK Onajole, S Lun, H Guo, B Merenbloom, G Vistoli, WR Bishai, ... Journal of medicinal chemistry 59 (13), 6232-6247, 2016 | 150 | 2016 |
Albumin is the main nucleophilic target of human plasma: a protective role against pro-atherogenic electrophilic reactive carbonyl species? G Aldini, G Vistoli, L Regazzoni, L Gamberoni, RM Facino, S Yamaguchi, ... Chemical Research in Toxicology 21 (4), 824-835, 2008 | 137 | 2008 |
The VEGA suite of programs: An versatile platform for cheminformatics and drug design projects A Pedretti, A Mazzolari, S Gervasoni, L Fumagalli, G Vistoli Bioinformatics 37 (8), 1174-1175, 2021 | 122 | 2021 |
Peptides Derived from Soy and Lupin Protein as Dipeptidyl-Peptidase IV Inhibitors: In Vitro Biochemical Screening and in Silico Molecular Modeling Study C Lammi, C Zanoni, A Arnoldi, G Vistoli Journal of Agricultural and Food Chemistry 64 (51), 9601-9606, 2016 | 116 | 2016 |
Bicyclic-capped histone deacetylase 6 inhibitors with improved activity in a model of axonal Charcot–Marie–Tooth disease S Shen, V Benoy, JA Bergman, JH Kalin, M Frojuello, G Vistoli, W Haeck, ... ACS chemical neuroscience 7 (2), 240-258, 2016 | 108 | 2016 |
Protein carbonylation: 2, 4-dinitrophenylhydrazine reacts with both aldehydes/ketones and sulfenic acids I Dalle-Donne, M Carini, M Orioli, G Vistoli, L Regazzoni, G Colombo, ... Free Radical Biology and Medicine 46 (10), 1411-1419, 2009 | 107 | 2009 |
Actin Cys374 as a nucleophilic target of α, β-unsaturated aldehydes I Dalle-Donne, M Carini, G Vistoli, L Gamberoni, D Giustarini, R Colombo, ... Free Radical Biology and Medicine 42 (5), 583-598, 2007 | 106 | 2007 |
Protein haptenation by amoxicillin: high resolution mass spectrometry analysis and identification of target proteins in serum A Ariza, D Garzon, DR Abánades, V de los Ríos, G Vistoli, MJ Torres, ... Journal of proteomics 77, 504-520, 2012 | 102 | 2012 |
Atom-type description language: a universal language to recognize atom types implemented in the VEGA program A Pedretti, L Villa, G Vistoli Theoretical Chemistry Accounts 109, 229-232, 2003 | 97 | 2003 |
Two peptides from soy β-conglycinin induce a hypocholesterolemic effect in HepG2 cells by a statin-like mechanism: Comparative in vitro and in silico modeling studies C Lammi, C Zanoni, A Arnoldi, G Vistoli Journal of agricultural and food chemistry 63 (36), 7945-7951, 2015 | 95 | 2015 |